Literature DB >> 17380318

Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy.

M García-Ramírez1, F Canals, C Hernández, N Colomé, C Ferrer, E Carrasco, J García-Arumí, R Simó.   

Abstract

AIMS/HYPOTHESIS: The aim of this study was to compare the protein profile of vitreous fluid from diabetic patients with proliferative diabetic retinopathy (PDR) with that from non-diabetic patients with idiopathic macular holes (MH). The mRNA of proteins differentially produced was also assessed in the retinas from diabetic and non-diabetic donors.
MATERIALS AND METHODS: Vitreous humour from type 1 diabetic patients with PDR (n = 8) and from non-diabetic patients with MH (n = 10) closely matched in terms of age were studied. The comparative proteomic analysis was performed using fluorescence-based difference gel electrophoresis (DIGE). Differentially produced proteins (abundance ratio >1.4, p < 0.05) were identified by mass spectrometry. Expressions of mRNA were measured by real-time RT-PCR in retinas from ten human eyes obtained at post-mortem (five eyes from diabetic subjects and five eyes from non-diabetic subjects).
RESULTS: Eight proteins were highly produced in PDR patients in comparison with non-diabetic subjects: zinc-alpha(2)-glycoprotein (ZAG), apolipoprotein (apo) A1, apoH, fibrinogen A, and the complement factors C3, C4b, C9 and factor B). We found three proteins that were underproduced in PDR subjects: pigment epithelial derived factor (PEDF), interstitial retinol-binding protein (IRBP) and inter-alpha-trypsin inhibitor heavy chain (ITIH2). There was no overlap in the vitreous levels of the above-mentioned proteins between PDR patients and non-diabetic control subjects. The differential production of ZAG, C3, factor B, PEDF and IRBP was further confirmed by western blot, and was in agreement with mRNA levels detected in the retina. CONCLUSIONS/
INTERPRETATION: Proteomic analysis by DIGE, which permits an accurate quantitative comparison, was useful in identifying new potential candidates involved in the pathogenesis of PDR.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17380318     DOI: 10.1007/s00125-007-0627-y

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  37 in total

Review 1.  Current two-dimensional electrophoresis technology for proteomics.

Authors:  Angelika Görg; Walter Weiss; Michael J Dunn
Journal:  Proteomics       Date:  2004-12       Impact factor: 3.984

2.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.

Authors:  D W Dawson; O V Volpert; P Gillis; S E Crawford; H Xu; W Benedict; N P Bouck
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

3.  Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients: possible role in the development of proliferative diabetic retinopathy.

Authors:  Rafael Simó; Albert Lecube; Laura Sararols; José García-Arumí; Rosa M Segura; Roser Casamitjana; Cristina Hernández
Journal:  Diabetes Care       Date:  2002-12       Impact factor: 19.112

4.  Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy.

Authors:  Jing Zhang; Chiara Gerhardinger; Mara Lorenzi
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

5.  Upregulation of pigment epithelium-derived factor after laser photocoagulation.

Authors:  N Ogata; J Tombran-Tink; N Jo; D Mrazek; M Matsumura
Journal:  Am J Ophthalmol       Date:  2001-09       Impact factor: 5.258

6.  Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes.

Authors:  Yi Bao; Chen Bing; Leif Hunter; John R Jenkins; Martin Wabitsch; Paul Trayhurn
Journal:  FEBS Lett       Date:  2005-01-03       Impact factor: 4.124

7.  Catalogue of soluble proteins in the human vitreous humor: comparison between diabetic retinopathy and macular hole.

Authors:  Toyofumi Nakanishi; Reiko Koyama; Tsunehiko Ikeda; Akira Shimizu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2002-08-25       Impact factor: 3.205

8.  Altered mouse cholinephosphotransferase gene expression in kidneys of type 2 diabetic KK/TA mouse.

Authors:  Tomohito Gohda; Mitsuo Tanimoto; Kenji Shiina; Takamichi Ito; Michimasa Kobayashi; Shinji Hagiwara; Shigeru Kaneko; Yuichiro Makita; Kazuhiko Funabiki; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  Metabolism       Date:  2004-07       Impact factor: 8.694

9.  A central role for inflammation in the pathogenesis of diabetic retinopathy.

Authors:  Antonia M Joussen; Vassiliki Poulaki; Minh Ly Le; Kan Koizumi; Christina Esser; Hanna Janicki; Ulrich Schraermeyer; Norbert Kociok; Sascha Fauser; Bernd Kirchhof; Timothy S Kern; Anthony P Adamis
Journal:  FASEB J       Date:  2004-07-01       Impact factor: 5.191

Review 10.  Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.

Authors:  Rafael Simó; Esther Carrasco; Marta García-Ramírez; Cristina Hernández
Journal:  Curr Diabetes Rev       Date:  2006-02
View more
  62 in total

Review 1.  Vitreous proteomics and diabetic retinopathy.

Authors:  Saloni Walia; Allen C Clermont; Ben-Bo Gao; Lloyd Paul Aiello; Edward P Feener
Journal:  Semin Ophthalmol       Date:  2010 Sep-Nov       Impact factor: 1.975

2.  Quantitative proteomic analyses of influenza virus-infected cultured human lung cells.

Authors:  Kevin M Coombs; Alicia Berard; Wanhong Xu; Oleg Krokhin; Xiaobo Meng; John P Cortens; Darwyn Kobasa; John Wilkins; Earl G Brown
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

Review 3.  Immunological mechanisms in the pathogenesis of diabetic retinopathy.

Authors:  Anthony P Adamis; Adrienne J Berman
Journal:  Semin Immunopathol       Date:  2008-03-14       Impact factor: 9.623

Review 4.  New insight into the role of the complement in the most common types of retinopathy-current literature review.

Authors:  Martyna Chrzanowska; Anna Modrzejewska; Monika Modrzejewska
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

5.  Proteomic analysis of human serum from diabetic retinopathy.

Authors:  Yin-Ping Liu; Shui-Wang Hu; Zhen-Feng Wu; Li-Xin Mei; Ping Lang; Xiao-He Lu
Journal:  Int J Ophthalmol       Date:  2011-12-18       Impact factor: 1.779

Review 6.  The role of complement system in ocular diseases including uveitis and macular degeneration.

Authors:  Purushottam Jha; Puran S Bora; Nalini S Bora
Journal:  Mol Immunol       Date:  2007-09       Impact factor: 4.407

Review 7.  The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier--implications for the pathogenesis of diabetic retinopathy.

Authors:  Rafael Simó; Marta Villarroel; Lídia Corraliza; Cristina Hernández; Marta Garcia-Ramírez
Journal:  J Biomed Biotechnol       Date:  2010-02-17

8.  Ocular proteomics with emphasis on two-dimensional gel electrophoresis and mass spectrometry.

Authors:  Bent Honoré; Henrik Vorum; Nakul Mandal; Steffen Heegaard; Jan Ulrik Prause
Journal:  Biol Proced Online       Date:  2009-12-24       Impact factor: 3.244

9.  Proteome Profiling of Vitreoretinal Diseases by Cluster Analysis.

Authors:  Tomomi Shitama; Hideyuki Hayashi; Sumiyo Noge; Eiichi Uchio; Kenji Oshima; Hisao Haniu; Nobuaki Takemori; Naoka Komori; Hiroyuki Matsumoto
Journal:  Proteomics Clin Appl       Date:  2008-09       Impact factor: 3.494

10.  Idiopathic preretinal glia in aging and age-related macular degeneration.

Authors:  Malia M Edwards; D Scott McLeod; Imran A Bhutto; Mercedes B Villalonga; Johanna M Seddon; Gerard A Lutty
Journal:  Exp Eye Res       Date:  2015-07-26       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.